ÀÚµ¿·Î±×¾Æ¿ô¾È³»
ÀÚµ¿ ·Î±×¾Æ¿ô ³²Àº ½Ã°£ : 30ÃÊ
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µË´Ï´Ù. ·Î±×ÀÎ ½Ã°£À» ¿¬ÀåÇϽðڽÀ´Ï´Ù?
ÀÚµ¿·Î±×¾Æ¿ô¾È³»
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µÇ¾ú½À´Ï´Ù.
±¸ºÐ | ºÐ·ù | Ç׸ñ | °¡°ÝÁ¤º¸ (´ÜÀ§ : ¿ø) | ƯÀÌ»çÇ× | ÃÖÁ¾º¯°æÀÏ | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
¸íĪ | ÄÚµå | ±¸ºÐ | ºñ¿ë | ÃÖÀúºñ¿ë | ÃÖ´ëºñ¿ë | Ä¡·áÀç·á´ë Æ÷ÇÔ¿©ºÎ |
¾àÁ¦ºñ Æ÷ÇÔ¿©ºÎ |
||||
MRI | ±Ù°ñ°Ý°è | MRI[Knee Marking]-À§Å¹¿¬±¸¿ë | 229,300 | 2019-09-02 | |||||||
MRI | ±Ù°ñ°Ý°è | MRI[°ß°üÀý Ã߽à 3] | 355,300 | 2024-01-01 | |||||||
¿µ»óÁø´Ü¹× ¹æ»ç¼±Ä¡·á·á | ¹æ»ç¼±´Ü¼ø¿µ»óÁø´Ü·á | Mammography 3-D tomosynthesis (Both) | GZ002 | 80,000 | 2020-08-24 | ||||||
¿µ»óÁø´Ü¹× ¹æ»ç¼±Ä¡·á·á | ¹æ»ç¼±´Ü¼ø¿µ»óÁø´Ü·á | Mammography 3-D tomosynthesis (Lt) | GZ002 | 40,000 | 2020-08-24 | ||||||
¿µ»óÁø´Ü¹× ¹æ»ç¼±Ä¡·á·á | ¹æ»ç¼±´Ü¼ø¿µ»óÁø´Ü·á | Mammography 3-D tomosynthesis (Rt) | GZ002 | 40,000 | 2020-08-24 | ||||||
Ä¡°úÀÇ º¸Ã¶·á | Ä¡°úÀÇ º¸Ã¶·á | Metal Post[´ë±¸Ä¡]::º¸»ó | 10090 | 60,000 | 2022-01-01 | ||||||
Ä¡°úÀÇ º¸Ã¶·á | Ä¡°úÀÇ º¸Ã¶·á | Metal Post[Àü.¼Ò±¸Ä¡]::º¸»ó | 130,000 | 2022-01-01 | |||||||
Ä¡°úÀÇ º¸Ã¶·á | Ä¡°úÀÇ º¸Ã¶·á | Miracle mix | 6,000 | 2018-03-26 | |||||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | NF1 gene mutation (MLPA) | CZ581 | 440,000 | 2017-09-16 | ||||||
ÃÊÀ½ÆÄ | µÎ°æºÎ | NS ³úÇ÷°ü ÃÊÀ½ÆÄ(ÃßÀû°Ë»ç 3ȸ) | EB481 | 244,100 | 2018-09-06 | ||||||
ÃÊÀ½ÆÄ | µÎ°æºÎ | NS ³úÇ÷°ü ÃÊÀ½ÆÄ(ÃßÀû°Ë»ç1ȸ) | EB481 | 184,600 | 2018-10-01 | ||||||
ÃÊÀ½ÆÄ | µÎ°æºÎ | NS ³úÇ÷°ü ÃÊÀ½ÆÄ(ÃßÀû°Ë»ç2ȸ) | EB481 | 244,100 | 2018-09-06 | ||||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | Noonan syndrom(PTPN11gene mutation) | CZ621 | 525,140 | 2017-01-16 | ||||||
°Ë»ç·á | ¼¼Æ÷¸é¿ª°Ë»ç | Oligomerized amyloid-beta (¿Ã¸®°í¸ÓÈ ¾Æ¹Ð·ÎÀÌµå º£Å¸) | CZ117 | 110,000 | 2024-04-01 | ||||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | Oncology(Her-2) FISH probe | 700,000 | 2017-01-16 |